Saras Capital (investor - Others)

See something wrong or missing? Let us know
Offices:London

Saras Capital is an investment vehicle used by Nadav Rosenberg

Average round investment:13.65M USD
Average number per year:2.3
Distribution: 2026 (1)2025 (3)2024 (3)
Mostly invests in: Ireland Ireland (2) Biotech (5)
See the entire list

Showing 3 of 7 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Saras Capital

Name Criteria
France Habert Dassault Finance
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Health services, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: France, Germany
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United States Cassius family
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Health services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: France, United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
France Wendel
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Software Services, Health services, AI (big data), Pharma, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: France
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Netherlands Rabo Frontier Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Software Services, Health services, AI (big data), Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United Kingdom Adjuvo Syndicate
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Health services, Pharma, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Germany Ventures Stars
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Health services, AI (big data), Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Israel Alex Bouaziz
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Health services, AI (big data), Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: France, United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Poland Orlen VC
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Software Services, AI (big data), Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: France, United Kingdom, Germany
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Belgium Sambrinvest
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Software Services, Health services, AI (big data), Pharma, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: France
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United States MS&AD Ventures
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Health services, AI (big data), Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Top